RYTM vs. TGTX

In the year-to-date period, RYTM achieves a 9.56% return, which is significantly lower than TGTX's 16.64% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Rhythm Pharmaceuticals, Inc. (RYTM) and TG Therapeutics, Inc. (TGTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current RYTM Sharpe Ratio is 1.33, which is comparable to the TGTX Sharpe Ratio of 1.73. The chart below compares the historical Sharpe Ratios of RYTM and TGTX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither RYTM nor TGTX has paid dividends to shareholders.

The maximum RYTM drawdown since its inception was -92.10%, smaller than the maximum TGTX drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for RYTM and TGTX.

The current volatility for Rhythm Pharmaceuticals, Inc. (RYTM) is 14.80%, while TG Therapeutics, Inc. (TGTX) has a volatility of 18.63%. This indicates that RYTM experiences smaller price fluctuations and is considered to be less risky than TGTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Rhythm Pharmaceuticals, Inc. and TG Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.